EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel Strategies for the Treatment of Asthma

Hajime Takizawa

Recent Patents on Inflammation & Allergy Drug Discovery · 2007

DOI: 10.2174/187221307779815101 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, 2007. Verfasst von Hajime Takizawa. Beteiligte Einrichtung: The Fourth Department of Internal Medicine, Teikyo University School of Medicine, 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki City 213-8507, Japan. takiz…. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is now clear that airway inflammatory processes characterized by eosinophils and Th2 lymphocytes are pivotal as the pathological features of asthma. Standard inhaled corticosteroids markedly suppress such inflammatory changes, resulting in clinical beneficial effects. However, it is also notified that airway wall remodeling including goblet cell hyperplasia, sub-epithelial collagen deposits, increased capillary networks and smooth muscle hypertrophy occur as a chronic consequence of this disorder even by the recommended strategies with steroid treatment. These pathologic changes play an important role in the increased airway obstruction and hyperresponsiveness, and eventually in the development of irreversible respiratory failure. Recent studies have elucidated that myofibroblasts and smooth muscle as well as mucosal epithelial cells play a vital role in these processes. Agents regulating proliferation, differentiation and activity of these cells, especially of low-molecular weight compounds, attract attention. Studies on molecular mechanisms of above processes, have led the development and patents of potential drugs including inhibitors of NF kappaB, statins, macrolides and phosphodiesterase-4 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAnti-Asthmatic AgentsAsthmaHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammationMacrolidesNF-kappa BPatents as TopicPhosphodiesterase 4 InhibitorsPhosphodiesterase Inhibitors

Substanzen

Anti-Asthmatic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsMacrolidesNF-kappa BPhosphodiesterase 4 InhibitorsPhosphodiesterase Inhibitors

Autor:innen und Institutionen

  • The Fourth Department of Internal Medicine, Teikyo University School of Medicine, 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki City 213-8507, Japan. takizawa@med.teikyo-u.ac.jp

Zitieren

APA

Takizawa, H. (2007). Novel Strategies for the Treatment of Asthma. Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/187221307779815101

Vancouver

Takizawa H. Novel Strategies for the Treatment of Asthma. Recent Patents on Inflammation & Allergy Drug Discovery. 2007. doi:10.2174/187221307779815101

BibTeX
@article{Takizawa2007,
  author = {Takizawa, Hajime},
  title = {Novel Strategies for the Treatment of Asthma},
  journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
  year = {2007},
  doi = {10.2174/187221307779815101}
}
Kostenlos starten →